Convergence
Biogen Idec buys Convergence
January 14, 2015Sales and Marketing BG00010, Biogen IDEC, CNV1014802, Colombia University Medical Center, Convergence, Neublastin
Biogen Idec is to acquire independent UK-based Convergence Pharmaceuticals to strengthen its pipeline of drugs for pain management in a …
Contract research news in brief
November 26, 2010Research and Development Chemir Analytical Services, Convergence, Cyanta, ICON, Iris Pharma, PRA, Proteome Sciences, Selcia, chiltern, contract research
Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, …
GSK takes stake in biotech spin-out
October 5, 2010Research and Development, Sales and Marketing Convergence, GlaxoSmithKline, funding
GlaxoSmithKline has taken a stake in a newly-launched biotech company in return for handing it two clinical compounds. The pharma …
Latest content
Global coalition calls for stronger government action on COPD
September 18, 2026
Global health researchers call for more equitable partnerships
September 17, 2026
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026
Circle Health Group expands into UK laboratory operations
September 15, 2026
